Subscribe to RSS
DOI: 10.1055/s-2006-939552
A Cell-Based Model of Thrombin Generation
Publication History
Publication Date:
02 May 2006 (online)

ABSTRACT
We have developed a cell-based model of thrombin generation using activated monocytes as a source of tissue factor (TF) and platelets serving as a surface for thrombin generation. Monocytes are activated by lipopolysaccharide and express cell-bound TF. To these are added physiologic (plasma) concentrations of all the plasma procoagulants as well as TF pathway inhibitor, antithrombin, and C1-esterase inhibitor. Coagulation takes place in microtiter wells and is initiated by factor VIIa (FVIIa) and calcium. At time intervals, aliquots are removed, platelet activation is measured by the expression of P-selectin, and thrombin generation is measured by chromogenic assay. In addition, one can measure the activation of FIX, FX, FVIII, FV, and FXI. Initial results reveal that the FVIIa-TF interaction results in the activation of FX to FXa and FIX to FIXa. FXa stays in the vicinity of the TF-bearing cell and, in the presence of FVa, converts a small amount of prothrombin to thrombin on the surface of the TF cell. This small amount of thrombin is not sufficient to clot fibrinogen, but is sufficient to activate platelets and FVIII, FV, and FXI. Following platelet activation, FVIIIa, FVa, and FXa occupy sites on the activated platelet surface. FIXa, activated by TF-FVIIa, does not remain on the TF cell, but converts FX to FXa on the platelet surface. FXIa acts to boost FIXa generation on the activated platelet, increasing FXa and subsequent thrombin generation. We have also shown that activated protein C does not inactivate Va on the platelet surface but rather on endothelial cell surfaces.
KEYWORDS
Factors V (FV) - FVIIa - FVIII - FIX - FIXa - FX - FXa - FXI - thrombin - thrombin generation - tissue factor
REFERENCES
- 1 Allen G A, Wolberg A S, Oliver J A et al.. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost. 2004; 2 402-413
- 2 Oliver J A, Monroe D M, Church F C, Roberts H R, Hoffman M. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood. 2002; 100 539-546
- 3 Monroe D M, Roberts H R, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol. 1994; 88 364-371
- 4 Hoffman M, Monroe D M, Oliver J A, Roberts H R. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood. 1995; 86 1794-1801
- 5 Monroe D M, Hoffman M, Oliver J A, Roberts H R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997; 99 542-547
- 6 Oliver J A, Monroe D M, Roberts H R, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol. 1999; 19 170-177
- 7 Wolberg A S, Monroe D M, Roberts H R, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 2003; 101 3008-3013
- 8 Wolberg A S, Gabriel D A, Hoffman M. Analyzing fibrin clot structure using a microplate reader. Blood Coagul Fibrinolysis. 2002; 13 533-539
- 9 Monroe D M, Hoffman M, Roberts H R. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis. 1996; 7 459-464
- 10 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991; 266 7353-7358
- 11 Gailani D, Broze Jr G J. Factor XI activation in a revised model of blood coagulation. Science. 1991; 253 909-912
- 12 Esmon C T, Owen W G. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA. 1981; 78 2249-2252
- 13 Camire R M, Kalafatis M, Cushman M et al.. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem. 1995; 270 20794-20800
- 14 Briede J J, Tans G, Willems G M, Hemker H C, Lindhout T. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets. J Biol Chem. 2001; 276 7164-7168
- 15 Hockin M F, Kalafatis M, Shatos M, Mann K G. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol. 1997; 17 2765-2775
- 16 Zwaal R F, Bevers E M. Platelet phospholipid asymmetry and its significance in hemostasis. Subcell Biochem. 1983; 9 299-334
- 17 Bevers E M, Comfurius P, Zwaal R F. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta. 1983; 736 57-66
- 18 Monroe D M, Hoffman M, Roberts H R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002; 22 1381-1389
- 19 Heemskerk J W, Bevers E M, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002; 88 186-193
- 20 Sumner W T, Monroe D M, Hoffman M. Variability in platelet procoagulant activity in healthy volunteers. Thromb Res. 1996; 81 533-543
- 21 Brummel-Ziedins K E, Pouliot R L, Mann K G. Thrombin generation: phenotypic quantitation. J Thromb Haemost. 2004; 2 281-288
Harold R RobertsM.D.
Professor, UNC School of Medicine, 932 Mary Ellen Jones Building
CB 7035, Chapel Hill, NC 27599-7035
Email: hrr@med.unc.edu